Drug-Coated Heart Stents News
Heart & Blood
> Drug-Coated Heart Stents
Latest Drug-Coated Heart Stents News
- Data from Randomized Pilot Study, Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008 8 May 2008 12:52 GMT
... Data from Randomized Pilot Study, Real-World Use of OrbusNeich's Genous(TM) ... with the Genous stent randomized with a drug eluting stent. In addition, de Winter will include ... a very important and promising alternative to drug-eluting stents," said de Winter. "EuroPCR is the ...
- Volcano Corp Announces First Human Use of the Volcano Optical Coherence Tomography (OCT) Imaging Catheter 8 May 2008 12:52 GMT
... Volcano Corp Announces First Human Use of the Volcano ... and assess the complete healing of novel drug-eluting stent designs. Volcano is committed to exploring the ...
- Data from Randomized Pilot Study, Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented i 8 May 2008 12:49 GMT
... Data from Randomized Pilot Study, Real-World Use of OrbusNeich's Genous(TM) ... with the Genous stent randomized with a drug eluting stent. In addition, de Winter will include ... a very important and promising alternative to drug-eluting stents," said de Winter. "EuroPCR is the ...
- Major Changes in Store for the US Drug-Eluting Stent Market 8 May 2008 12:48 GMT
... Major Changes in Store for the US Drug-Eluting Stent Market Major Changes in Store for ... Interventional Cardiology Marketrack(TM) results indicate that Medtronic's drug eluting stent (DES), Endeavor, captured significant US market ...
- Volcano Corporation, Q1 2008 Earnings Call Transcript 8 May 2008 05:26 GMT
... Good afternoon everyone thanks for holding and welcome to ... the leading cath lab equipment manufactures and stent companies. This includes our newest collaboration with ... guided therapy products that combine IVUS with Drug-Eluting Stent. The initial authoring will be a ...
- BUYINS.NET: MIVT, NEOM, UTLM, CKNWF, ISYFF, EBFD Have Also Been Removed From Naked Short List Today 7 May 2008 17:37 GMT
... May 07, 2008 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, ... of advanced biocompatible coatings for passive and drug-eluting applications on cardiovascular stents, as well as ... research program on the "Development of Novel Drug Eluting Composite Coatings for Cardiovascular Stents," under the ...
- BUYINS.NET: MIVT, NEOM, UTLM, CKNWF, ISYFF, EBFD Have Also Been Removed From Naked Short List Today 7 May 2008 17:37 GMT
... May 07, 2008 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, ... of advanced biocompatible coatings for passive and drug-eluting applications on cardiovascular stents, as well as ... research program on the "Development of Novel Drug Eluting Composite Coatings for Cardiovascular Stents," under the ...
- Sorin Group Announces Earnings for Q1-2008 Exceeding Guidance - Full Year Guidance Confirmed 7 May 2008 16:49 GMT
... Sorin Group Announces Earnings for Q1-2008 Exceeding Guidance - ... our transformation towards becoming a strong and consistent performer. We are focusing on profitability improvements ... accelerating. -- The Vascular Therapy Business Unit (drug-eluting and bare-metal coronary stents, endovascular stents and ...
- XTENT Announces Clinical Trial Data to be Presented at Annual EuroPCR Meeting Next Week 7 May 2008 12:57 GMT
... XTENT Announces Clinical Trial Data to be Presented at ... also sponsoring an evening symposium on customizable drug-eluting stents and will exhibit throughout the meeting ... trial evaluating use of the Custom NX(R) Drug Eluting Stent (DES) System in patients with long ...
- Zilver Stent for PAD 7 May 2008 04:31 GMT
... The so-called 'zilver' stent is coated with paclitaxel - a chemotherapy ... used to open blocked arteries in the heart - may put patients back on their ... first trial to examine the use of drug-coated stents." The so-called 'zilver' stent is coated with ...
- Don't ask, don't tell: Financial disclosure lacking in literature on stents 7 May 2008 01:51 GMT
... Don't ask, don't tell: Financial disclosure lacking in literature on stents DURHAM, NC Most published research about coronary ... types of stents: bare metal stents and drug-eluting stents, and the medical and scientific communities ...
- Medtronic to cut 1,100 jobs 6 May 2008 22:37 GMT
... a difficult quarter for the company's core cardiac rhythm disease management business, due to a ... quarter with the launch of its Endeavor drug-coated stents in the United States and the addition ...
- Medical device maker Medtronic to cut 1,100 jobs from slow-growth units 6 May 2008 21:52 GMT
... a difficult quarter for the company's core cardiac rhythm disease management business due to a ... quarter with the launch of its Endeavor drug-coated stents in the United States and the addition ...
- Medtronic to cut 1,100 jobs from global work force 6 May 2008 20:36 GMT
... a difficult quarter for the company's core cardiac rhythm disease management business due to a ... quarter with the launch of its Endeavor drug-coated stents in the United States and the addition ...
- Cardiovascular Stent Technology Evolving to Address Therapeutic Shortfall 6 May 2008 16:50 GMT
... Applied Data Research Analyzes Emerging Technologies, Evolving Opportunities for ... Opportunities for the Next Generation of Cardiovascular Stents (Nashua, NH) - The introduction of the drug eluting stent (DES) has been a significant development ...
- MIV Therapeutics Featured in Cardiovascular Business News 6 May 2008 12:15 GMT
... ATLANTA, GA--(Marketwire - May 6, 2008) - MIV Therapeutics, ... "the potential for the company's second-generation VESTAsync drug-eluting stent (DES), the impressive nine-month preliminary results ... research program on the "Development of Novel Drug Eluting Composite Coatings for Cardiovascular Stents," under the ...
- InspireMD Announces Positive 6-Month Efficacy And Safety Results Of The MGuard(TM) Coronary Stent 6 May 2008 09:35 GMT
... InspireMD announced continued positive results from the MGuard™ Coronary ... continued positive results from the MGuard™ Coronary Stent First-in-Man, multi-center ongoing trial in Germany. This ... disease. The data is comparable with existing drug eluting stents, particularly the late loss and restenosis ...
- UPDATE 1-Boston Scientific gets favorable patent ruling 5 May 2008 22:58 GMT
... Intellectual Property Organization ruled that the company's stents do not infringe patents held by Israel's Medinol ... that Boston Scientific's Liberte and Taxus Liberte drug-coated stents infringed various U.S. and European patents held ... are small wire-mesh tubes used to open arteries after doctors have cleared them of blockages. ...
- RealPennies.com: Turning Pennies into dollars: (OTCBB: LGDI), (OTCBB: BMOD), (OTC:PGSVY), (OTCBB:MIVT). 5 May 2008 16:18 GMT
... RealPennies.com: Turning Pennies into dollars: (OTCBB: LGDI), (OTCBB: ... headquarters at Lysaker, Norway. MIV'S VESTAsync Polymer-Free Drug-Eluting Stent to Be Highlighted at Several Presentations ... research program on the "Development of Novel Drug Eluting Composite Coatings for Cardiovascular Stents," under the ...
- Businessnetwire.us: Stocks in the News: MIVT, HTRE, BCFT, WNRC 5 May 2008 15:16 GMT
... Businessnetwire.us: Stocks in the News: MIVT, HTRE, BCFT, ... News- May 5, 2008: MIV'S VESTAsyncTM Polymer-Free Drug-Eluting Stent to Be Highlighted at Several Presentations at ...
- Stockwire.com: CHAT LIVE in the only dedicated CHAT ROOM for MIV Therapeutics, Inc. (OTCBB:MIVT) shareholders! 5 May 2008 15:16 GMT
... Stockwire.com: CHAT LIVE in the only dedicated CHAT ... May 5, 2008 - MIV'S VESTAsync Polymer-Free Drug-Eluting Stent to Be Highlighted at Several Presentations ... research program on the "Development of Novel Drug Eluting Composite Coatings for Cardiovascular Stents," under the ...
- MIV'S VESTAsync(TM) Polymer-Free Drug-Eluting Stent to Be Highlighted at Several Presentations at Eu 5 May 2008 14:13 GMT
... MIV'S VESTAsync(TM) Polymer-Free Drug-Eluting Stent to Be Highlighted at Several Presentations ... research program on the "Development of Novel Drug Eluting Composite Coatings for Cardiovascular Stents," under the ...
- MIV'S VESTAsync(TM) Polymer-Free Drug-Eluting Stent to Be Highlighted at Several Presentations at EuroPCR 5 May 2008 13:56 GMT
... ATLANTA, GA--(Marketwire - May 5, 2008) - MIV Therapeutics, ... that its VESTAsync™ polymer-free nanoscale microporous hydroxyapatite drug-eluting stent will be included in several presentations ... research program on the "Development of Novel Drug Eluting Composite Coatings for Cardiovascular Stents," under the ...
- Cardiva Medical, Inc. Completes $15.5 Million Private Equity Financing 5 May 2008 13:16 GMT
... MOUNTAIN VIEW, Calif., May 5 /PRNewswire/ -- Cardiva Medical, ... behind the launch of the world's first drug-eluting stent the CYPHER(R) Sirolimus-eluting Coronary Stent. "We are ...
- BUYINS.NET: IGPG, MIVT, SOLM, AVTI, ISYFF, NEWCQ Have Also Been On BUYINS.NET Naked Short List For 13 Consecutive Trading Days 5 May 2008 13:15 GMT
... May 05, 2008 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, ... of advanced biocompatible coatings for passive and drug-eluting applications on cardiovascular stents, as well as ... research program on the "Development of Novel Drug Eluting Composite Coatings for Cardiovascular Stents," under the ...
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
CK - Dovolená - Chorvatsko, Egypt, Tunisko, Turecko, Řecko, ItálieDovolenka - Last Minute - Zájazdy - Egypt, Grécko, TalianskoYoga Studio Prague - Prague Yoga, Yoga Prague, Czech Yoga, Yoga Classes
|
themoneytimes.com:
washingtonpost.com:
cbsnews.com:
abcnews.go.com:
yahoo.com:
reuters.com:
